Skip to main content
Tech.euFundingExplorerBeta

Biocross

Biocross is a biotechnology company develops blood tests for the diagnosis of Alzheimer’s disease.

Total raised
€450k
€450,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-08
latest 2021-08

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood11
base rate 30% for Other
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds

Related news

Similar companies

same sector or country